MuraliMChakinalaMD
Pulmonology • Saint Louis, MOCritical Care Medicine, Pulmonary Vascular Medicine
Associate Professor, Internal Medicine, Washington University School of Medicine
Dr. Chakinala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
Fl 8
Saint Louis, MO 63110Phone+1 314-454-8917Fax+1 314-454-5571
Summary
- Dr. Murali Chakinala is a pulmonologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital and Barnes-Jewish West County Hospital. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 23 years. He specializes in pulmonary vascular diseases, thromboembolic disease and general pulmonology.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2002
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1994 - 1998
Vanderbilt University School of MedicineClass of 1994
Certifications & Licensure
IL State Medical License 2022 - 2026
MO State Medical License 2000 - 2025
TX State Medical License 1996 - 1999- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Best Doctors in America 2011-2019
- Outstanding Physician of the Year Pulmonary Hypertension Association, 2014
Clinical Trials
- Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia Start of enrollment: 2010 Apr 08
- Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
- North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Start of enrollment: 2011 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial.Steven M Kawut, Rui Feng, Susan S Ellenberg, Roham Zamanian, Todd Bull
American Journal of Respiratory and Critical Care Medicine. 2024-11-01 - Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective.Sandeep Sahay, Murali M Chakinala, Nick H Kim, Ioana R Preston, Thenappan Thenappan
American Journal of Respiratory and Critical Care Medicine. 2024-09-01 - US commercial health plan coverage dynamics in pulmonary arterial hypertension therapies.Julia A Rucker, Molly T Beinfeld, Daniel E Enright, Hayley D Germack, Sumeet Panjabi
Journal of Managed Care & Specialty Pharmacy. 2024-06-01
Press Mentions
PAH Care Turns Corner with New Therapies, Intensified MonitoringFebruary 8th, 2022
A Deep Dive into Pulmonary HypertensionJanuary 21st, 2019
PhaseBio Announces Dosing of First Patient in Phase 2b Clinical Trial of PB1046 in Pulmonary Arterial HypertensionNovember 27th, 2018- Join now to see all
Grant Support
- Impact Of Community-Acquired Respiratory Viral Infecions In Lung TransplantNational Center For Research Resources2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
